相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Influenza Virus-Cytokine-Protease Cycle in the Pathogenesis of Vascular Hyperpermeability in Severe Influenza
Siye Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Immunomodulation and matrix metalloproteinases in viral myocarditis
Dirk Westermann et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review
Charlotte Warren-Gash et al.
LANCET INFECTIOUS DISEASES (2009)
Matrix Metalloproteinases in the Pathogenesis of Viral Heart Disease
David Marchant et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2009)
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice
Caroline Cheung et al.
CIRCULATION (2008)
Induction of inflammatory cytokine release from human umbilical vein endothelial cells by agonists of proteinase-activated receptor-2
Qing-Xia Niu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza, associated encephalopathy
Dengbing Yao et al.
HUMAN MUTATION (2008)
Cardiovascular manifestations associated with influenza virus infection
Mamas Andreas Mamas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents
Hiroshi Kido et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-α-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-κB and AP-1
Seok-Jong Suh et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Genetic background of pancreatitis
Masahiko Hirota et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Influenza vaccination as secondary prevention for cardiovascular disease - A science advisory from the American Heart Association/American College of Cardiology
Matthew M. Davis et al.
CIRCULATION (2006)
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis
Stephane Heymans et al.
CIRCULATION (2006)
Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis
Rosemarijn Renckens et al.
JOURNAL OF IMMUNOLOGY (2006)
Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response
M Steinhoff et al.
ENDOCRINE REVIEWS (2005)
Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-κB inhibitor
A Matsumori et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts
T Tatsumi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Cytokine-induced modulation of cardiac function
SD Prabhu
CIRCULATION RESEARCH (2004)
Is the failing heart energy starved? On using chemical energy to support cardiac function
JS Ingwall et al.
CIRCULATION RESEARCH (2004)
Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat
HS Rosário et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1,-8,-13) and stromelysin-1 (MMP-3) and degrades type I collagen
M Moilanen et al.
BIOCHEMISTRY (2003)
Anoikis in the cardiovascular system - Known and unknown extracellular mediators
JB Michel
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells
P Nyberg et al.
JOURNAL OF DENTAL RESEARCH (2002)
分享论文
